PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74820-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74820-8/fulltext
Title : PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74820-8&doi=10.1016/S1098-3015(10)74820-8
First page :
Section Title :
Open access? : No
Section Order : 745
Categories :
Tags :
Regions :
ViH Article Tags :